A novel SREBF1::NACC1 gene fusion in an unclassifiable intracranial tumour

Neuropathol Appl Neurobiol. 2022 Dec;48(7):e12843. doi: 10.1111/nan.12843. Epub 2022 Aug 17.

Abstract

A 39-year-old man had an intracranial tumour without infiltration into the surrounding cerebral tissue. The tumour recurred seven times in 11 years but maintained a well-demarcated character. Histopathological examination of the 4th surgical specimens showed nests of tumour cells surrounding small blood vessels. The tumour cells harboured amphophilic cytoplasm and small round nuclei with fine chromatin, and perinuclear haloes and clear borders were frequently observed, which was unclassifiable histology. By the Deutsches Krebsforschungszentrum methylation classifier, the tumour was not classified into any of the methylation classes. mRNA sequencing identified a novel SREBF1::NACC1 gene fusion. This intracranial tumour could be a novel tumour entity with NACC1 rearrangement showing characteristic histological and diagnostic imaging findings.

Keywords: SREBF1::NACC1 gene fusion; intracranial tumour; methylation-based classification; unclassifiable tumour.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain Neoplasms*
  • Gene Fusion*
  • Humans
  • Male
  • Neoplasm Proteins
  • Repressor Proteins
  • Sterol Regulatory Element Binding Protein 1

Substances

  • SREBF1 protein, human
  • Sterol Regulatory Element Binding Protein 1
  • NACC1 protein, human
  • Neoplasm Proteins
  • Repressor Proteins